Clinical trials
Phase 1/2 Vulvar Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Christian Hinrichs | 1 |
| Incyte Corporation | 1 |
| Marengo Therapeutics, Inc. | 1 |
| SCG Cell Therapy Pte. Ltd. | 1 |
| Sichuan Enray Pharmaceutical Sciences Company | 1 |
| University of Florida | 1 |
| Yuhan Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vulvar Neoplasms | 9 |
| Uterine Cervical Neoplasms | 7 |
| Vaginal Neoplasms | 4 |
| Anus Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Oropharyngeal Neoplasms | 3 |
| Penile Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.